Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 DAC (2mg Vial) Dosage Chart - Peptide Dosages

CJC-1295 DAC (2mg Vial) Dosage Protocol Long-acting GHRH analog (DAC) — research/educational dosing reference. Concerned about side effects? See CJC-1295 side effects — what the research documents (honest, sourced, research-use-only). Mix & measure CJC-1295 DA

CJC-1295 DAC (2mg Vial) Dosage Protocol

Long-acting GHRH analog (DAC) — research/educational dosing reference.

Concerned about side effects? See CJC-1295 side effects — what the research documents (honest, sourced, research-use-only).

Mix & measure CJC-1295 DAC · 2 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Dosing & Reconstitution Guide

A single practical dilution with accurate twice-weekly dosing, step by step

Standard / Gradual Approach (2 mL = 1 mg/mL)

Reconstitute: Add 2.0 mL bacteriostatic water to one 2 mg vial → final concentration 1 mg/mL (1,000 mcg/mL).

Typical dose range: 300–1000 mcg per injection, twice weekly, raised gradually over an 8–12 week course.

Easy measuring: At 1 mg/mL, 1 unit = 10 mcg (0.01 mL) on a U-100 syringe. Units = dose (mg) ÷ 1, so 1 mg lands at 100 units (1.0 mL).

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

CJC-1295 DAC (2 mg Vial) & Ipamorelin (5 mg Vial) Dosage Protocol

GHRH analog (CJC-1295 DAC) + ghrelin-receptor GH secretagogue (Ipamorelin) — two separate research-only vials; the combination is not clinically validated.
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

1. CJC-1295 DAS Research

CJC-1295 stimulate growth hormone release in a pulsatile manner like natural GHRH [2]. Research in mice with GHRH gene ablation found that administration of CJC-1295 resulted in normal body weight and length, suggesting it might be effective in treating growth-related disorders [3]. CJC-1295 has long half and prolonged duration of action. One study found its association with a 2-3 fold increase in growth hormone for 6 days and a 1.5-1.3 fold increase in IGF-1 levels for 9-11 days [1].

RESEARCH

Research Liquids

Albuterol 5MG/ML | 30ML with dropper Anastrozole 1.5MG/ML | 30ML with dropper Clomiphene 50MG/ML | 30ML with dropper Finasteride 5MG/ML | 30ML with dropper Letrozole 3.5 MG/ML | 30ML with dropper LiquiCia 30MG/ML | 30ML with dropper LiquiCia T50 50MG/ML | 30ML with dropper LiquiClen 200MCG/ML | 30ML with dropper Liquistane / Exemestane 25MG/ML | 30ML with dropper LiquiTamo 20MG/ML | 30ML with dropper LiquiVia 25MG/ML | 30 ML with dropper T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper Toremifene Citrate 60MG/ML | 30ML with dropper Yohimbine HCL 10MG/ML | 30ML with dropper